Immune Escape Associated with Functional Defects in Antigen-Processing Machinery in Head and Neck Cancer
Open Access
- 1 July 2006
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 12 (13) , 3890-3895
- https://doi.org/10.1158/1078-0432.ccr-05-2750
Abstract
Recent revival of interest in the role of immune surveillance in the pathogenesis and control of malignant diseases has focused attention on escape mechanisms used by tumor cells to evade immune recognition. Defects in the host's tumor antigen–specific immune responses and abnormalities in tumor cell expression of HLA class I molecules and tumor antigen are known to contribute to tumor progression. However, the mechanism(s) responsible for the lack of tumor cell recognition by functional HLA class I antigen–restricted, tumor antigen–specific CTLs despite expression of the restricting HLA class I allele and targeted tumor antigen by tumor cells remain(s) unexplained. In squamous cell carcinomas of the head and neck (SCCHN), this type of tumor escape is a rule rather than the exception. Here, we discuss evidence pointing to functional defects in the antigen-processing machinery as one mechanism underlying resistance of SCCHN cells to recognition and lysis by HLA class I antigen–restricted, tumor antigen–specific CTL. In addition, based on the restoration by IFN-γ of SCCHN cell sensitivity to recognition by these CTL, we suggest strategies that may improve the clinical course of the disease by enhancing susceptibility of malignant cells to immune recognition.Keywords
This publication has 33 references indexed in Scilit:
- Immune suppression in cancer: Effects on immune cells, mechanisms and future therapeutic interventionSeminars in Cancer Biology, 2006
- Development and characterization of human constitutive proteasome and immunoproteasome subunit‐specific monoclonal antibodiesTissue Antigens, 2005
- Involvement of both intrinsic and extrinsic pathways in IFN-γ-induced apoptosis that are enhanced with cisplatinEuropean Journal Of Cancer, 2005
- Molecular Staging of Cervical Lymph Nodes in Squamous Cell Carcinoma of the Head and NeckCancer Research, 2005
- High Frequency of Functionally Active Melan-A–Specific T Cells in a Patient with Progressive Immunoproteasome-Deficient MelanomaCancer Research, 2004
- A listing of human tumor antigens recognized by T cells: March 2004 updateCancer Immunology, Immunotherapy, 2004
- Development of effective immunotherapy for the treatment of patients with cancerJournal of the American College of Surgeons, 2004
- Interferon-? sensitizes colonic epithelial cell lines to physiological and therapeutic inducers of colonocyte apoptosisJournal of Cellular Physiology, 2000
- Transfection of TAP 1 gene restores HLA class I expression in human small-cell lung carcinomaInternational Journal of Cancer, 1998
- Immunomodulatory Function of Interferon-Gamma in Patients with Metastatic Melanoma: Results of a Phase II-B Trial in Subjects with Metastatic Melanoma, ECOG Study E 4987Journal of Immunotherapy, 1997